Systemic interleukin 12 displays anti-tumour activity in the mouse central nervous system.

In various systemic cancers, interleukin 12 (IL-12) induces anti-tumour immunity mediated by T lymphocytes and natural killer cells. To determine whether IL-12 has anti-tumour activity against malignant gliomas in the central nervous system (CNS), which is considered to be an immunologically privile...

Descripción completa

Detalles Bibliográficos
Autores principales: Kishima, H., Shimizu, K., Miyao, Y., Mabuchi, E., Tamura, K., Tamura, M., Sasaki, M., Hakakawa, T.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group|1 1998
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063094/
https://www.ncbi.nlm.nih.gov/pubmed/9716025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063094/
https://www.ncbi.nlm.nih.gov/pubmed/9716025

Ejemplares similares